In this study, 10 males with breast cancer were screened for mutations in BRCA1 and BRCA2. Besides, the patients were characterized for immunohistochemical features such as ER, PR, Her-2, and CK5/6 tissue tumor markers. The gene discussed is BRCA2; the disease is breast cancer.